<DOC>
	<DOC>NCT02123199</DOC>
	<brief_summary>A prospective observational multi centre research study in GP practices clustered within up to 10 UK Primary care trusts.</brief_summary>
	<brief_title>Study of the Impact of Indacaterol (OnbrezÂ®) on the Individual Lives and Health Status of Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Patients with active diagnosis of COPD, confirmed by spirometry documented in medical notes Patients who are currently receiving other maintenance therapy (except LAMA) for COPD. Patients previously prescribed Indacaterol.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>COPD</keyword>
</DOC>